Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric L Snyder

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Translational Lung Cancer Research|April 14, 2023
TTF-1 and immune checkpoint therapy in non-small cell lung cancerMatthew Gumbleton, Eric L Snyder
Expert Opinion on Drug Delivery|November 22, 2005
Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivoEric L Snyder, Steven F Dowdy
Pharmaceutical Research|April 9, 2004
Cell penetrating peptides in drug deliveryEric L Snyder, Steven F Dowdy
Biochemical Society Transactions|April 2, 2026
The role of HNF4α in adenocarcinomaHeadtlove Essel Dadzie, Eric L Snyder
Cell|April 3, 2012
SnapShot: Lung cancer modelsAnna F Farago, Eric L Snyder, Tyler Jacks
STAR Protocols|January 10, 2026
Protocol to extract and sort GFP-tagged nuclei from lung adenocarcinoma tissue in genetically engineered mouse modelsKatherine Gillis, Walter A Orellana, Eric L Snyder
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 3, 2026
TTF-1-Negative Lung Adenocarcinoma: An Aggressive Subtype Refractory to Immunotherapy and KRAS<sup>G12C</sup> InhibitionHenry U Arnold, Wallace Akerley, Eric L Snyder
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 23, 2003
Anti-cancer protein transduction strategies: reconstitution of p27 tumor suppressor functionEric L Snyder, Bryan R Meade, Steven F Dowdy
Journal of Gastrointestinal Oncology|January 4, 2019
The role of lineage specifiers in pancreatic ductal adenocarcinomaSoledad A Camolotto, Veronika K Belova, Eric L Snyder
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 3, 2009
Identification of CD44v6(+)/CD24- breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodiesEric L Snyder, Dyane Bailey, Michail Shipitsin, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Translational Lung Cancer Research|April 14, 2023
TTF-1 and immune checkpoint therapy in non-small cell lung cancerMatthew Gumbleton, Eric L Snyder
Expert Opinion on Drug Delivery|November 22, 2005
Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivoEric L Snyder, Steven F Dowdy
Pharmaceutical Research|April 9, 2004
Cell penetrating peptides in drug deliveryEric L Snyder, Steven F Dowdy
Biochemical Society Transactions|April 2, 2026
The role of HNF4α in adenocarcinomaHeadtlove Essel Dadzie, Eric L Snyder
Cell|April 3, 2012
SnapShot: Lung cancer modelsAnna F Farago, Eric L Snyder, Tyler Jacks
STAR Protocols|January 10, 2026
Protocol to extract and sort GFP-tagged nuclei from lung adenocarcinoma tissue in genetically engineered mouse modelsKatherine Gillis, Walter A Orellana, Eric L Snyder
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 3, 2026
TTF-1-Negative Lung Adenocarcinoma: An Aggressive Subtype Refractory to Immunotherapy and KRAS<sup>G12C</sup> InhibitionHenry U Arnold, Wallace Akerley, Eric L Snyder
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 23, 2003
Anti-cancer protein transduction strategies: reconstitution of p27 tumor suppressor functionEric L Snyder, Bryan R Meade, Steven F Dowdy
Journal of Gastrointestinal Oncology|January 4, 2019
The role of lineage specifiers in pancreatic ductal adenocarcinomaSoledad A Camolotto, Veronika K Belova, Eric L Snyder
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 3, 2009
Identification of CD44v6(+)/CD24- breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodiesEric L Snyder, Dyane Bailey, Michail Shipitsin, et al.
Pageof 6